《港樓》大埔「林海山城」山城徑26號洋房以逾5,738萬元售出
由希慎(00014.HK)及香港興業(00480.HK)發展的大埔露輝路低密度豪宅項目「林海山城」,本月至今錄得兩宗成交,套現近7,300萬元。其中山城徑26號洋房屬五房兩套間隔,實用面積3,294平方呎,成交價5,738.7萬元,折合呎價約17,422元。
另一售出單位為第2座2樓C室,為標準單位,實用面積1,187平方呎,屬三房一套連工人套房設計,成交價1,543萬元,呎價約13,000元。
香港興業國際集團有限公司銷售及市務助理總經理陳秀珍透露,項目開售至今售出及出租單位累計138伙,其中買賣總成交金額近30億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.